The treatment of organophosphate (OP) poisoning consists of the administration of a parasympatholytic agent, an anticonvulsant and an acetylcholinesterase (AChE) reactivator. Since there is no broad AChE reactivator available, a post-treatment strategy currently exploits administration of different types of oximes depending on the exposure of OP. In this contribution, we summarize all the available data about AChE reactivator HLö-7 including its synthesis, physico-chemical properties, pharmacokinetic and pharmacodynamics profile, and its efficacy in vitro and in vitro.
INTRODUCTION
The human central nervous system (CNS) is based on a complex interaction of nerves through neurotransmitters, highly important small molecules, by which the activity of multiple organs, glands, or other neurons is kept in a dynamic balance. 1, 2 From a large group of these molecules we should particularly emphasize acetylcholine (ACh; Fig. 1 ) which is involved in the autonomic and also in the peripheral nervous systems as a major skeletal muscle activator.
The anionic site ( Fig. 2 ; purple carbon atoms) consisting of Trp86, Tyr133, Tyr337 and Phe338 (hAChE numbering) is responsible for interaction with quaternary ammonium group through cation-π-interactions. In other words, this anionic region provides proper orientation of the substrate within the gorge under physiological condition. 7 The oxyanion hole ( Fig. 2 ; blue carbon atoms) is composed of Gly122, Gly121 and Ala204 (hAChE numbering). It stabilizes the substrate transition state after nucleophilic attack via hydrogen bonds. 7 The acyl pocket ( Fig. 2 ; salmon carbon atoms) being composed of Phe295 and Phe297 (hAChE numbering) is relevant for substrate specificity, thus preventing entrance of bulky molecules into the catalytic center. 7 The so-called peripheral anionic site (PAS; Fig. 2 ; green carbon atoms) is located at the entrance of the gorge. The PAS is composed of Tyr72, Asp74, Tyr124, Tyr286 and Tyr341 ( h AChE numbering) and it is responsible for the first contact with various substrates including inhibitors. 7 The action of AChE active site is further supported by auxiliary molecules (water etc.). Some water molecules are buried and distributed inside specific areas of the cavity. A second type are conserved water molecules. 8 The knowledge about the conformation of the active site residues together with water molecules is necessary for the structure-based design of AChE modulators.
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AChE inhibitors/AChE inhibition
The AChE enzyme is the target of a structurally diverse group of compounds. It is the primary target for deadly and poisonous chemicals related to organophosphorus (OP) compounds (OPCs) such as pesticides or chemical warfare agents (CWAs) (Fig. 3) . For instance, the representatives of pesticides are malathion, parathion, paraoxon or diazinon. The second group, CWAs, is often misused in armed conflicts or by terrorists (Iraq 1980s; Tokyo 1995; Syria 2013). CWAs can be further subdivided base on their structure into G-agents (tabun, sarin, soman or cyclosarin) and V-agents (VX or RVX). 10, 11 Chemically, all these structures could be denoted as esters of phosphoric or phosphonic acid and their thio-analogues. 12 The different structure of OP pesticides and the CWAs anticipates different degree of toxicity but similar mechanism of AChE inhibition. The example of hAChE inhibition by CWA VX is described in Fig. 4 . 13, 14 The first step is rapid phosphorylation (covalent interaction through P-O bond formation) of the Ser203 hydroxyl group from catalytic triad. The electrophilic phosphorous atom is liable to the nucleophilic attack of hydroxyl group from serine. Depending on the chemical structure of OPs, these agents bind to AChE with different affinity and thus inducing various changes in the conformation of residues in the enzyme active site. This reaction leads to form OP-AChE conjugate with consequent inhibition of the AChE hydrolytic activity. The process results into ACh accumulation in the peripheral and central tissues of the nervous system promoting excessive overstimulation of cholinergic receptors (nicotinic and muscarinic) leading to deleterious effects, such as ocular pain, blurred vision, tightness of the chest, wheezing, bronchial constriction and secretion and ultimately respiratory failure and death. 6, 13, [15] [16] [17] At this stage AChE may be spontaneously reactivated by hydrolytic cleavage of OPs-AChE conjugate or another intramolecular reaction can occur. In the latter case, it is a spontaneous process of irreversible dealkylation of alkoxy group bonded to the phosphorous atom and intermolecular stabilization of the organophosphoryl-AChE complex by a donor-acceptor bond with the proximal histidine residue (His447 in hAChE). This process known as "aging" makes restoration of AChE activity by any reactivator no longer possible. Because of diverse chemical structures of OPs, the OP-AChE complex exhibits different half-life of aging (e.g. soman 2-4 minutes; sarin 5-12 hours; tabun 46 hours; VX 48 hours) which is important for better antidote treatment. [16] [17] [18] [19] The similarity between murine AChE (mAChE) and hAChE helped to describe in detail the mechanism of OPs binding. 20 The OPs binding is directed by its covalent bond with the catalytic serine (Ser203 on hAChE). The stabilization of the complex depends on electrostatic and hydrophobic interactions between OPs and Trp86, Tyr124, Glu202, Trp236, Phe297, Tyr337 and His447. Phe297 is able to rotate 180° for allowing the entrance of OPs. In another words, it acts as a swinging gate. 21 Exerting high degree of homology to h AChE, m AChE was used to describe differences in interactions of tabun with aged and non-aged form of mAChE (Fig. 5 ). The main difference between both forms is the direct formation of a hydrogen bond between oxygen from OPs and hydrogen from catalytic His447 in the aged conformation.
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AChE reactivation and reactivators
Reactivation of AChE
Before an aged complex of OP-AChE is formed, it can be easily hydrolytically cleavedto yield replenished free enzyme. This process can be managed via nucleophilic attack of oximate anion, derived from compounds bearing an oxime functional group. Such attack takes the electron-deficient phosphorus atom attached to the Ser203 residue of OPs-AChE complex of hAChE, cleaves the phosphoester bond forming phosphylated oxime and dephosphylated, fully active, AChE (Fig. 6 ). The resulting reactivation of AChE allows the enzymeto maintain the physiological levels of ACh. Nowadays we are able to predict if the chosen reactivator for OP-inhibited-AChE will be potential or not. At first we have to know their physicochemical properties, especially acid dissociation constant (pK a ), lipophilicity (logP), polar surface area (PSA), hydrogen bond donor and acceptor counts (HBD and HBA) are essential. 23 Determination of pK a for an oxime is crucial to diagnose the effective pH at which the oximate moiety can be formed and thus can attack the OP-AChE adduct in order to reactivate the enzyme. Lipophilicity is one of the main descriptors known for blood-brain barrier (BBB) penetration describing the involvement of oxime molecule in lipids phase with respect to hydrophilic phase and ability to penetrate the lipid bilayer membrane to reach target site. Polar surface area (PSA) is the sum of all polar atoms (nitrogen and oxygen) with hydrogen in the oxime reactivator. It is an important parameter for drug transport properties prediction. Hydrogen-bond donors (HBD) (sum of OH and NH groups) and hydrogen-bond acceptors (HBA) (sum of O and N atoms) also play a crucial role in prediction of distribution of molecule through BBB. [24] [25] [26] [27] Reactivators of AChE.
By 2017, the most potential and commonly used reactivators of AChE belong to the group of quaternary oximes (Fig. 8) or non-quaternary oximes (Fig. 9) . 6, [28] [29] [30] 75 Uncharged reactivators represent a new hope in the therapy of OP intoxication. However, their potential implication in the OP-countermeasure is still on the long road ahead. Mainly, these compounds are hampered by inappropriate drug-like properties. From this point of view, their physiochemical properties need to be optimized. On the other hand, uncharged reactivators represent viable and brand-new approach how to increase the BBB permeation. Since all these drawbacks have not been fully addressed so far, we still have to rely on the pyridiniumbased AChE reactivators. A few decades ago, these charged reactivators have been developed and since then only a few more with an interesting profile and concomitantly overwhelming the capability of currently used oximes have been introduced (K027 or K203) 31 . In this regard, particular attention is paid to Hlö-7 being considered one of the most potent bis-pyridinium reactivator with broad profile.
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HLö-7 -history, physico-chemical properties, syntheses, biological profile
History and physico-chemical properties of HL ö-7
HLö-7 diiodide (Fig. 10) was first synthesized by Löffler in 1986. It is structurally related to HI-6, but it possesses an additional aldoxime function in position 4. This additional aldoxime functional group also plays a crucial role in reactivation of AChE inhibited by OPs. HLö-7 diiodide was found to be a very efficient reactivator of AChE inhibited by tabun, soman, sarin and diisopropyl fluorophosphate (DFP). Major limitations of HLö-7 diiodide represents its relatively low solubility in water and poor stability. 33 Combination of HLö-7 diiodide with atropine ( Fig. 11) , muscarinic blocker, was very effective against intoxication by 3×LD 50 of soman, sarin or cyclosarin and 2×LD 50 of tabun. These promising results highlighted HLö-7 as a very broad spectrum oxime reactivator. 34 The problem of solubility in water and relative instability was solved by preparationof HLö-7 dimethanesulfonate salt ( 
Syntheses of HLö-7 dimethanesulfonate
The introduction of dimethyl-acetal bridge between two basic scaffolds is a problematic issue because it uses carcinogenic bis(chloromethyl)ether as an alkylating agent. Its substitution to non-mutagenic bis(methylsulfonoxymethyl)ether not only solved this problem but also led to water-soluble hybrid HLö-7 dimethanesulfonate. 32 Accordingly, HLö-7 dimethanesulfonate can be prepared by two different routes either from pyridine-2,4-dialdoxime and isonicotinamid in reaction with bis(methylsulfonoxomethyl)ether or from HLö-7 diiodide by ion exchange (Fig. 13) . More in detail, firstly described synthetic approach starts with a dropwise addition of pyridine-2,4-dialdoxime in dry tetrahydrofuran (THF) at 40°C with moisture exclusion (drying tube) to a solution of bis(methylsulfonoxymethyl)ether in dry acetonitrile (MeCN). Yellow mono-quarternary intermediate, 2,4-bis(hydroxyiminomethyl)-1-(methylsulfonoxymethoxymethyl)-pyridinium methanesulfonate started to crystallize and crystallization was complete after 8 hours stirring at room temperature. Solids were filtered off and the residue reacted with isonicotinamide in dry MeCN, being added dropwise. In the last step, the reaction mixture was stirred at room temperature for 1 hour and at 40°C for 3 hours. Solvent was removed under reduced pressure and the crude product was re-crystalized with methanol, filtered and kept on ice following addition of one drop of methanesulfonic acid. Colorless crystals were recrystallized from MeOH twice and dried over P 2 Second approach started with dropwise addition of water at 60°C to a methanol suspension of HLö-7 diiodide. Methanesulfonic acid was used to reach pH = 3.5 -4 and then silver methanesulfonate in MeCN was added. The precipitated AgI was extracted with a small volume of MeOH and filtrate was reduced to 20 mL. Filtrate was recrystallized from MeOH. The overall yield for ion-exchange was 95%. 32 The 1 H NMR spectrum of prepared HLö-7 dimethanesulfonate was measured in D 2 O and DMSO confirming the structure acquiring similar data to HLö-7 diiodide (Table 1) . 32 HPLC analysis of HLö-7 dimethanesulfonate gave information about formation of five major by-products. These were identified as de-aminated by-product of HLö-7 ("HLö-7 acid"; (1-[[[4-(carboxy) pyridinio]methoxy]methyl]-2,4-bis[(hydroxyimino)methyl]pyridinium dimethanesulfonate). Further, pyridine-2,4-dialdoxime was identified. The other confirmed impurity was the dimer of pyridine-2,4-dialdoxime tethered via dimethylacetal bridge. The last two signals were assigned to syn/anti isomer and the major signal was for syn/syn isomer (Fig. 14) . The structure of last impurity has not been elucidated. 32 Figure 14 . Side-products identified during HPLC analysis of HLö-7 dimethanesulfonate
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Pharmacokinetics, pharmacodynamics, antidotal efficacy and toxicity in rodents and dogs
Pharmacokinetics of HLö-7 was studied on male beagles weighing 17.1 +/-0.9 kg after i.v. or i.m. injection within 30 seconds (20 μmol/kg of HLö-7 dimethanesulfonate). The plasma concentration of HLö-7 after i.v. injection of HLö-7 dimethanesulfonate was established proposing that the distribution period ( l t 1/2 about 5 minutes) and terminal elimination was found to be first-order throughout ( e t 1/2 about 45 minutes). 32 HLö-7 dimethanesulfonate was administered into the gluteal muscles to four male beagles. Absorption halftime was about 14 minutes, maximum plasma concentrations were found about 30 minutes after injection and elimination fits the kinetics observed after i.v. injection. 32 The urinary recovery of HLö-7 was 85% after i.v. injection but only 76% after i.m. injection. Urinary tests did not detect any of HLö-7 metabolites in urine. 32 Pharmacodynamics of HLö-7 was studied on anaesthetized guinea-pigs of both sexes, weighting 250-350 g. Influence of HLö-7 dimethanesulfonate (30 μmol/kg or 100 μmol/kg injected i.v.) on heart rate, arterial blood pressure and respiratory minute volume was compared to control group (closed circle).
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Compound
Mice* Guinea-pig* Both doses of HLö-7 dimethanesulfonate decreased heart rate after being injected till the end of 5 minute. For 30 μmol/kg dose heart rate increased from 91-92 % to 95-96 % between 10 minutes and 30 minutes, from 30 minutes it was increased to starting value. 32 Both doses of HLö-7 dimethanesulfonate decreased arterial blood pressure after i.v. injection. For the dose of 100 μmol/kg arterial blood pressure was decreased by 40 % and for 30 μmol/kg dose 10 % decrease of arterial blood pressure was recorded after 5 minutes. 32 Respiratory minute volume (%) was influenced only at a dose of 100 μmol/kg dose. In the first five minutes it was increased up-to 135 -137 % of normal values, then decreased in the next 15 minutes to 100%. Similar observation was made for the dose of 30 μmol/kg. 32 Reactivation of phosphonylated/inhibited AChE was studied using bovine red cell membrane AChE. This AChE was inhibited by soman or sarin at pH 8.5 and 5 °C (conditions used for non-aged soman-AChE adduct) and the activity was determined at pH 7.4 and 37 °C after removal of unbound organophosphate. 32 For soman-AChE non-aged complex, the enzyme activity was replenished from 8 to 47 % within 5 minutes after HLö-7 administration and remained for 90 minutes measuring period. HI-6 dichloride was able to increase activity from 5 to 30 % and obidoxime dichloride from 3 to 9 % within 5 minutes. 32 Regarding sarin-AChE complex, this was almost completely reactivated when using all three oximes. For HLö-7 dimethanesulfonate and obidoxime dichloride the reactivation rate were rapid from 2 to 75 % of enzyme activity within 5 minutes and much slower when using HI-6 dichloride. 32 For HLö-7 diiodide, HLö-7 dimethanesulfonate and HI-6 dichloride LD 50 s were established after i.m. administartion in female NMRI mice and male Dunkin-Harley guinea-pigs (Table 2) . 32 HLö-7 diiodide, HLö-7 dimethanesulfonate and HI-6 dichloride were administered in combination with atropine to assess their antidotal potency (ED 50 -dose of an oxime which reduced lethality from >95 % to 50 %) against soman (1.2 LD 50 ), sarin (3 LD 50 ) and tabun (3 LD 50 Atropine alone was not able to reduce lethality from > 95 % to 50 %. Similar observations can be made for HI-6 dichloride in case of tabun poisoning. HLö-7 (both salts) was more potent than standard HI-6 dichloride in soman and sarin intoxication. 32 Table 4 summarizes efficacy of the oximes in combination with atropine to countermeasure soman, sarin and tabun posioning. All the oximes+atropine were injected i.m. 1 minute after poisoning. [48] Atropine alone slightly improved survival rate which is indicative of increased LD 50 value. HI-6 dichloride in a maximum tolerated dose (722 μmol/kg) in combination with atropine (57.6 μmol/kg) demonstrated higher antidotal efficacy against soman compared to HLö-7 diiodide (210 μmol/kg) and also improved efficacy than HI-6 dichloride (244 μmol/kg) with 28.8 μmol/kg atropine in mice. The 3-3.5 higher dose of HI-6 dichloride presumably caused better antidotal efficacy in guinea-pigs. In sarin and tabun poisoning, HLö-7 (both salts) and HI-6 dichloride displayed similar antidotal efficacy. 32 Effect on survival time and survival rate by using combination of atropine (28.8 μmol/kg) and/or HLö-7 dimethanesulfonate (30 μmol/kg or 100 μmol/kg) against soman poisoning (5 × LD 50 ) was studied on anaesthetized male guinea-pigs (Table 5) . Soman was injected i.v. followed by atropine and/or HLö-7 dimethanesulfonate i.v. 2 minutes later. 32 Obtained data showed that atropine alone (28.8 μmol/kg) increased survival time from 6 to about 30 minutes and also survival rate was increased to 2/6. Both doses of HLö-7 dimethanesulfonate were ineffective. Lower dose of HLö-7 dimethanesulfonate (30.0 μmol/kg) combined with atropine was the most effective, i.e. survival time was 56.5 +/-2.5 minutes and survivors/non-survivors ratio was 6/2. Higher dose of 100.0 μmol/kg did not exert to provide any therapeutic benefits; survival time was 47.6 +/-8.1 minutes and ratio between survivors/nonsurvivors was 6/2. 32 Lastly, effects of different antidotal combinations on motor performance of male mice were studied. The running time on a rotating mesh-wire drum (diameter 20 cm; 14 rpm) was determined. The mice were sub-divided into five groups of ten animals and each group was allowed to run on the drum for 1 hour, time record was made for each mouse individually.
First group represented control group, second group was soman-poisoned (s.c., 0.6 μmol/kg), third group received combination of soman injected (s.c.; 0.6 μmol/kg) and atropine injected i.p. This experiment showed that combination of atropine (28.8 μmol/kg) and HLö-7 dimethanesulfonate (30 μmol/kg ) was the first one that increased running time. The highest increase of running time was observed when using higher dose of HLö-7 dimethanesulfonate (from 30 to 150 μmol/kg).
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CONCLUSION
In this work we focused on HLö-7 (diidodide and dimethanesulfonate) in terms of its development and characterization by physico-chemical properties. Two possible syntheses of HLö-7 dimethanesulfonate were mentioned and described in detail. Last but not least we discussed pharmacokinetic and pharmacodynamic profile performed on rodents and dogs. The toxicity (LD 50 ) of HLö-7 diiodide, HLö-7 dimethanesulfonate and HI-6 dichloride in mice and guinea-pigs were measured and compared. Antidotal effectiveness (antidotal potency and efficacy) of mentioned oximes in combination with atropine and motor performance were studied also on mice and guinea-pigs. All these experiments highlighted HLö-7 as a potential drug candidate against OPs countermeasure.
